Terumo's $1.5B OrganOx acquisition marks a bold move into organ preservation, targeting faster growth and diversification beyond legacy markets. Normothermic machine preservation technology could ...
After making a significant strategic investment in Oxganox Ltd. earlier this year, Terumo Corp. returned to buy the company. This morning, the companies announced that Terumo would acquire Organox for ...
Organox Ltd. raised $142 million in financing to accelerate the growth of its Metra platform that preserves and transport livers for transplantation. The funds will allow the company to strengthen its ...
OXFORD, United Kingdom and MADISON, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd., a leading organ medical technology company, successfully completed a $142 million primary and secondary equity ...
"This FDA approval is a major step forward for the transplant community," said Craig Marshall, CEO of OrganOx. "By enabling air transport of donor livers on the metra ®, we're removing key logistical ...
TransMedics Group Inc. (NASDAQ:TMDX) is one of the best mid cap growth stocks to invest in now. On June 17, Oppenheimer increased the price target for TransMedics to $150 from $130, while maintaining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback